The rollercoaster ride continued on Wall Street today, but stocks swung back near breakeven in late trading to save what could have been a very bad day. In early trading the Dow Jones Industrial Average (DJINDICES: ^DJI ) dropped 127 points on the back of a big overnight drop in the Japanese stock market and a report showing contraction in China's manufacturing. HSBC said preliminary data for its Purchasing Managers' Index in China showed a reading of 49.6, which signals slight contraction and continues a streak of falling numbers. But by the last hour of the trading session, Wall Street had moved on from problems in Japan and China, and the Dow was down just 0.06%, while the S&P 500 (SNPINDEX: ^GSPC ) had fallen 0.25%. �
The big headline of the day was Hewlett-Packard's (NYSE: HPQ ) surprise earnings beat and the stock's 16.4% jump today. After the market closed last night the company reported�adjusted earnings per share of $0.87 and a 10% decline in fiscal second-quarter revenue to $27.6 billion. Both were enough to beat estimates, and the $0.06 earnings beat was the big driver of the stock's move today. Better-than-expected earnings from HP are great, but let's not forget that every operating segment is in decline, and profit only beat expectations by virtue of massive cost-cutting efforts.�
5 Best Small Cap Stocks To Watch For 2016: Puma Biotechnology Inc (PBYI)
Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.
PB272 (neratinib (oral))-Breast Cancer
Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.
PB272 (neratinib (intravenous))
The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.
PB357
PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.
The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.
Advisors' Opinion:- [By George Budwell]
With that being said, developmental biotechs that fall hard on news could be worth taking a look at because they may have fallen for all the wrong reasons. Puma Biotechnology (NYSE: PBYI ) , for example, plummeted by 25% about a month ago after reporting mid-stage clinical trial data for the company's flagship cancer drug PB272 (neratinib).
Top 10 Japanese Companies To Watch In Right Now: First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN)
First Trust NASDAQ Clean Edge US (ETF) seeks investment results that correspond to the price and yield of an equity index of the NASDAQ Clean Edge U.S. Liquid Series Index. It is a market capitalization weighted index designed to track the performance of clean energy companies that are publicly traded in the United States and includes companies engaged in manufacturing, development, distribution and installation of emerging clean-energy technologies, including solar photovoltaics, biofuels and advanced batteries.
The NASDAQ Clean Edge U.S. Liquid Series Index is a modified market cap weighted index in which larger companies receive a larger index weighting. First Trust Advisors L.P. is the adviser of the fund.
Advisors' Opinion:- [By Todd Shriber, ETF Professor]
The news was predictably good for a pair of ETFs that should be known as "Tesla ETFs." The Market Vectors Global Alternatve Energy ETF (NYSE: GEX) and the First Trust NASDAQ Clean Edge Green Energy Index Fund (NASDAQ: QCLN) both traded higher on a down day for U.S. stocks, rising to within pennies of their previous 52-week highs.
Top 10 Japanese Companies To Watch In Right Now: Shanda Games Ltd (GAME)
Shanda Games Limited (Shanda Games), incorporated on June 12, 2008, is engaged in the development and operation of online games and related businesses in the People��s Republic of China. Some of its online games are also Web games, which the Company categorizes as either massively multiplayer online role-playing games (MMORPGs) or advanced casual games, rather than as a separate category of online games. As of February 29, 2012, Shanda Games operated 35 online games. Its game player base, which consisted of 20.4 million average monthly active users and 4.5 million average monthly paying users for the three-month period ended December 31, 2011. In April 2011, the Company acquired a 51.85% interest in a game operating company, which provides services in East Asia.
As of December 31, 2011, the Company owned 149 software copyrights. As of December 31, 2011, it owned or licensed 53 trademarks. As of December 31, 2011, it owned or licensed 329 registered domain names, including its official Website and domain names registered in connection with each of the games the Company offers. As of December 31, 2011, it had 17 patent applications pending with the State Intellectual Property Office of China. The Company operates MMORPGs, advanced casual games and Web games in China. Its MMORPGs are action adventure-based and draw upon themes, such as martial arts adventure, fantasy, strategy and historical events. The Company develops and sources an array of game content through multiple channels, including in-house development, licensing, investment and acquisition, and joint operation. Through these channels, it has built a diversified game portfolio and a game pipeline.
The Company licenses games from international and domestic developers. As of February 29, 2012, 13 of its 35 online games were licensed from third-party developers, including Mir II. It invests in independent game development and operating studios identified by 18 Capital. The Company acquire intellectual property rights t! o online games; equity rights in online game development and operating studios, or an option to acquire equity interests in online game development and operating studios in the future.
The Company operates its business in People's Republic of China, through its wholly owned subsidiaries, which consist of Shengqu Information Technology (Shanghai) Co., Ltd. (Shengqu), Shengji Information Technology (Shanghai) Co., Ltd. (Shengji), Lansha Information Technology (Shanghai) Co., Ltd. (Lansha) and Kuyin Software (Shanghai) Co., Ltd (Kuyin); its variable interest entities and their subsidiaries (VIEs), which consist of Shanghai Hongli Digital Technology Co., Ltd. (Shanghai Hongli) and Shanghai Shulong Technology Development Co., Ltd. (Shanghai Shulong) and their wholly owned subsidiaries, Shanghai Shulong Computer Technology Co., Ltd. (Shulong Computer), Nanjing Shulong Computer Technology Co., Ltd. (Nanjing Shulong), Chengdu Youji Technology Co., Ltd. (Chengdu Youji), Tianjin Youji Technology Co., Ltd. (Tianjin Youji), Chengdu Aurora Technology Development Co., Ltd. (Chengdu Aurora), and Chengdu Simo Technology Co., Ltd. (Chengdu Simo).
The Company competes with Tencent Holdings Limited, NetEase.com, Changyou.com Limited, Perfect World Co., Ltd., Giant Interactive, Kingsoft Corporation Limited, KongZhong Corporation, NetDragon Websoft Inc., Nineyou International Limited, The9 Limited, Activision Blizzard, Inc., Electronic Arts Inc., Zynga Inc., NCSoft Corporation, and Nexon Corporation.
Advisors' Opinion:- [By Kevin Chen]
Two companies that seem on an unstoppable path of profits are Giant Interactive� (NYSE: GA ) and NetEase (NASDAQ: NTES ) .�Meanwhile, Shanda Games� (NASDAQ: GAME ) and Perfect World� (NASDAQ: PWRD ) haven't done as well.
- [By James E. Brumley]
In a perfect world, Oasis Petroleum Inc. (NYSE:OAS) and Shanda Games Limited (NASDAQ:GAME) would always reflect the true underlying value of their respective companies. In reality, GAME and OAS are both well-watched, and frequently-traded, stocks that can take on a life of their own, reflecting ever-changing opinions of the companies rather than the companies' actual value. There's an upside to that disconnect, however - knowing each chart may or may not reflect the actual value of Shanda Games Limited and Oasis Petroleum means you can take the clues given to us by their chart. After all, since charts are just a reflection of public opinion, and since public opinion is actually rather predictable, the way things appear to be - visually - may actually be the way things are. And in this case, the way things are with OAS happens to be a polar opposite with the way things are with GAME.
- [By Lauren Pollock]
Shanda Games Ltd.'s(GAME) third-quarter earnings fell 1.6% despite growth in the game developer’s revenue driven by its mobile-game segment. Morgan Stanley(MS) analysts aren’t impressed with the company’s PC game pipeline, while sales of its top PC games dropped in the latest period. Shares declined 5.1% to $3.90 premarket.
- [By Evan Niu, CFA]
What: Shares of Shanda Games (NASDAQ: GAME ) have popped today by as much as 11% after the game maker launched a new title with early success.
Top 10 Japanese Companies To Watch In Right Now: Tellabs Inc.(TLAB)
Tellabs, Inc. designs, develops, and supports telecommunications networking products for communication service providers in the United States and internationally. Its products and services enable customers to deliver wireless and wireline voice, data, and video services to business and residential customers. The company operates through three segments: Broadband, Transport, and Services. The Broadband segment provides access products that enable service providers to deliver bundled voice, video, and high-speed Internet/data services over copper or fiber networks; managed access products, which deliver wireless and business services primarily outside of North America; and data products, including packet-switched products that enable wireless and wireline carriers to deliver mobile voice and Internet services, and wireline business services to their customers. The Transport segment enables service providers to manage network bandwidth by adding capacity needed; and wireline and wireless providers to support metro networks, mobile services, and business services for enterprises, as well as triple-play voice, video, and data services for residential consumers. The Services segment delivers deployment, training, support, and professional services, which support various phases of the network, such as planning, building, and operating. Tellabs, Inc. serves primarily communication services providers, including local exchange carriers; wireline and wireless service providers; multiple system operators; competitive service providers; distributors; original equipment manufacturers; system integrators; and government agencies. The company sells its products and services through its direct sales and sales support personnel, value-added resellers, independent sales representatives, distributors, and public and private network providers. Tellabs, Inc. was founded in 1974 and is headquartered in Naperville, Illinois.
Advisors' Opinion:- [By Rich Smith]
You have to hand it to Tellabs (NASDAQ: TLAB ) -- they work fast.
Late last month, the networking equipment maker had to scramble when its acting chief financial officer, Tom Minichiello, announced plans to retire on July 12 to become the new CFO at Westell Technologies (NASDAQ: WSTL ) . On Friday, though, just as the deadline was happening, Tellabs announced that it has found a replacement.
- [By Rick Munarriz]
Thursday
Tellabs (NASDAQ: TLAB ) checks in on Thursday. The provider of mobile backhaul, packet optical, and services solutions to communications services lost its CEO to colon cancer last year. It has also lost its mojo. Wall Street sees Tellabs merely breaking even in 2013 on a 14% decline in revenue. - [By SA Pro Top Ideas]
Stock Movers and Great Calls
Saidal Mohmand argued Wednesday that Tellabs (TLAB) was a strong assets play on the verge of a turnaround. The stock is +5.9% since. Read article » On June 13, Stephen Lin said that Ellie Mae's (ELLI) dominant position could mean 45% upside. Shares are +30.7% since. Read article »
Alpha-Rich long and short ideas regularly move stocks and identify stocks that are about to move. Some notable recent calls subscribers had early access to:To Come Today
Don't forget to check your SA Pro dashboard later today for the latest Alpha-Rich ideas, including a REIT with strong management and many catalysts. Any thoughts to share on the latest Alpha-Rich ideas? Leave a comment here. Have a great weekend.
SA Pro Editors
…............
The SA Pro team is Eli Hoffmann (Editor in Chief), Rachael Granby (Editorial Product Manager), Daniel Shvartsman, Samir Patel, Michael McDonald, and Jeffrey Fischer (Senior Pro Editors). You can reach us at pro-editors@seekingalpha.com. - [By Selena Maranjian]
The biggest new holdings are Seagate Technology�and Warner Chilcott. Other new holdings of interest include Tellabs (NASDAQ: TLAB ) and Windstream (NASDAQ: WIN ) . Tellabs offers a satisfying dividend yield of 3.7%, but the networking equipment maker has been facing some headwinds, such as the death of its CEO and the recent departure of its CFO. Its performance has been spotty, besting estimates in its fourth quarter but disappointing them in the recent first quarter.
Top 10 Japanese Companies To Watch In Right Now: Aberdeen Australia Equity Fund Inc (IAF)
Aberdeen Australia Equity Fund, Inc. (the Fund) is a closed-end, non-diversified management investment company. The Fund��s principal investment objective is long-term capital appreciation through investment primarily in equity securities of Australian companies listed on the Australian Stock Exchange Limited. Its secondary objective is current income, which is expected to be derived primarily from dividends and interest on Australian corporate and governmental securities. The Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities, consisting of common stock, preferred stock and convertible stock, of companies tied economically to Australia (each an Australian Company), and at least 65% of its total assets in equity securities, consisting of common stock, preferred stock and convertible stock, listed on the Australian Stock Exchange Limited (ASX). Advisors' Opinion:- [By Dividends4Life]
According to a Gabelli Funds report, managed distribution policies offer several advantages, including:1. Lower difference between the fund��s market price and its NAV per share.2. Provides support during periods when the stock market is in a decline.3. Provides a measurable performance target for the investment adviser.Below are several high-yield funds from CEFA that have a managed distribution policy (yields as of December 16):Aberdeen Australia Eqty (IAF)- Distribution Yield: 10.4%- Income Yield: 3.46%Bexil Advisers LLC� (DNI)- Distribution Yield: 11.1%- Income Yield: 3.56%BlackRock En Capital&Inc (CII)- Distribution Yield: 8.78%- Income Yield: 2.34%Cornerstone Strat Value (CLM)- Distribution Yield: 18.77%- Income Yield: 1.83%Cornerstone Total Return (CRF)- Distribution Yield: 19.10%- Income Yield: 0.85%Delaware Inv Div & Inc (DDF)- Distribution Yield: 6.70%- Income Yield: 5.26%Gabelli Equity Trust (GAB)- Distribution Yield: 7.58%- Income Yield: 1.54%Gabelli Utility Trust (GUT)- Distribution Yield: 9.45%- Income Yield: 2.84%MFS Special Value Trust (MFV)- Distribution Yield: 9.60%- Income Yield: 5.73%Nuveen Tx-Adv TR Strat (JTA)- Distribution Yield: 6.70%- Income Yield: 3.12%TCW Strategic Income (TSI)- Distribution Yield: 10.54%- Income Yield: 7.88%Zweig Total Return (ZTR)- Distribution Yield: 7.27%- Income Yield: 1.95%As noted in the Gabelli report, a managed distribution policy may create confusion regarding the true current yield since the reported yield includes the return of capital portion. You can see the disparity above between the income yield and the distribution (reported) yield.If you are looking for a sustainable and growing dividend, you may want to consider some blue-chip dividend stocks such as these with a Free Cash Flow Payout less than 50%, 50+ years of consecutive dividend increases and a 2%+ yield:3M Co. (MMM) is a diversified global company provides enhanced product functionality in electronics, health care, industrial, consumer
Top 10 Japanese Companies To Watch In Right Now: Cereplast Inc (CERPQ)
Cereplast, Inc. (Cereplast), incorporated on September 29, 2001, is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. The Company primarily conducts its operations through product families, such as Cereplast Compostables resins, Cereplast Hybrid Resins and Cereplast Algae Plastic resins. In October 2011, the Company purchased a manufacturing plant in Assisi (Cannara).
Cereplast Compostables resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. The Company offers 13 commercial grades of Compostable resins in this product line. Cereplast Sustainables resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications. The Company offers six commercial grades of Sustainable resins in this product line. Cereplast Hybrid Resins products replace up to 55% of the petroleum content in conventional plastics with bio-based materials, such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins, such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. The first commercial product with Cereplast Algae Plastic resin is being produced and sold as part of the Company's Sustainables resin family.
The Company's Compostable resins are renewable substitutes for petroleum-based plastics targeting primarily single-use disposables. The Company's Compost! able Resins have been used to produce foodservice ware, including the first line of fully biodegradable and compostable foodservice ware. Cereplast Hybrid Resins uses renewable materials such as starches from corn and tapioca.
Cereplast competes with BASF, Dow Chemical, Lyondell Basell, DuPont, SABIC, Novamont, NatureWorks and Telles.
Advisors' Opinion:- [By Bryan Murphy]
The whole thing may seem a little "out there" at first glance, but truth be told, what Metabolix, Inc. does isn't terribly unusual anymore. It's just a little less sexy than what traders and stock speculators usually want to see and hear with their picks. Kraton Performance Polymers Inc. (NYSE:KRA) and the now-bankrupt Cereplast Inc. (OTCMKTS:CERPQ) are/were in the same business, along with several others. [Don't let the Cereplast bankruptcy filing deter you - it wasn't a lack of opportunity that up-ended CERP.]
Top 10 Japanese Companies To Watch In Right Now: Progenics Pharmaceuticals Inc.(PGNX)
Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases in the United States and internationally. Its primary programs focus on gastroenterology, oncology, and virology. The company offers RELISTOR (methylnaltrexone bromide) subcutaneous injection, a therapy for opioid-induced constipation. It is also conducting a Phase I clinical trial of a human monoclonal antibody-drug conjugate directed against prostate specific membrane antigen (PSMA), a protein found at high levels on the surface of prostate cancer cells, as well as in blood vessels supplying other solid tumors. In addition, the company is developing PRO 140, a viral-entry inhibitor for human immunodeficiency virus (HIV), which is in Phase II clinical testing; and multiplex PI3-Kinase inhibitors for the treatment of cancer. Progenics Pha rmaceuticals, Inc. has license agreement with Salix Pharmaceuticals, Ltd. for the development and commercialization of RELISTOR worldwide other than Japan. The company was founded in 1986 and is based in Tarrytown, New York.
Advisors' Opinion:- [By Anna Prior]
A U.S. Food and Drug Administration office has approved Salix Pharmaceuticals Ltd.'s(SLXP) appeal to gain approval for expanded usage of a constipation drug it licensed from Progenics Pharmaceuticals Inc.(PGNX), the companies said. Shares of Progenics climbed 12% to $4.75 premarket.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Progenics Pharmaceuticals (NASDAQ: PGNX ) has received a distressing two-star ranking.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Progenics Pharmaceuticals (NASDAQ: PGNX ) has received a distressing two-star ranking.
No comments:
Post a Comment